Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
At Navitas Life Sciences, we stand as a leading oncology CRO, delivering cutting edge solutions that optimize trial design, enhance patient recruitment, and accelerate regulatory approvals. With over 100 oncology clinical studies conducted, we bring deep expertise in solid and hematological tumors, including breast, lung, gastric, HCC, prostate, mu...
What is a CRO? A Contract Research Organization (CRO) is a strategic partner to pharmaceutical, biotechnology, and medical device companies, providing outsourced research activities that facilitate the efficient execution of clinical trials and regulatory processes. CROs offer expertise across clinical development, regulatory affairs, pharmacovigil...
Glaucoma remains a leading cause of irreversible blindness worldwide, affecting millions of people and posing significant challenges for healthcare systems. Despite advancements in diagnostics and treatment, the complexity of the disease—characterized by its silent progression and multifactorial nature—demands a continuous evolution i...
The US Food and Drug Administration (FDA) recently provided a draft guidance on the application of artificial intelligence (AI) in regulatory decision making. By championing a balance between innovation and safety, this initiative highlights the significance of AI while upholding its rigorous scientific and regulatory standards. Entitled ‘Co...
The clinical trials landscape in 2025 is shaped by technological advancements, regulatory shifts, and a growing demand for innovative therapies. In our latest blog we explore key developments that are poised to leave a lasting impact on clinical trials. 1. AI and Machine Learning: Moving from Hype to Practical Applications Artificial Intelligence (...
The second Medical Roundtable provided a rich platform for industry leaders to discuss strategies, innovations, and challenges in medical writing outsourcing. There were 11 attendees from across 8 companies, and the discussions emphasized the importance of strategic foresight, technological integration, and the optimal balance between insourcing an...
In the pharmaceutical industry, where data drives innovation and ensures regulatory compliance, sound data governance practices are critical. This is because data is at the heart of the most recent innovative breakthroughs, like Artificial Intelligence (AI), Machine Learning (ML) and Data Science (DS). Without a high-quality, well understood datase...
Diversity, equity, and inclusion (DEI) are no longer optional ideals for organizations. They are essential drivers of innovation, employee engagement, and sustainable growth. While many companies have made strides toward ensuring inclusive workplaces, the gap between intention and implementation remains significant. Addressing this gap requires not...
Thailand’s pharmaceutical and clinical trials industry is undergoing a transformative phase, positioning itself as a critical player in the global healthcare ecosystem. As the demand for innovative solutions grows, regulatory complexities, market dynamics, and therapeutic advancements converge to create a challenging yet promising environmen...
As a trusted diabetes CRO, we’re honoured to recognize World Diabetes Day and this year’s theme, 'Breaking Barriers and Bridging Gaps.' This theme calls on us to confront the critical challenges and inequalities that prevent effective diabetes care. Millions around the world struggle to access the healthcare, education, and resources ...